Direct Warming Frozen Embryo Transfer Outcomes in Assisted Reproductive Technology

Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 15, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to warm frozen embryos before transferring them to women undergoing in vitro fertilization (IVF). The researchers want to find out if a direct warming method, which is quicker and simpler, can lead to more successful pregnancies and live births compared to the traditional multi-step warming method. They will also assess whether this new method saves money. Women aged 18 to 45 who have at least one high-quality embryo ready for transfer may be eligible to participate.

If you join the study, you will either receive the direct warming method or the conventional method to thaw your embryo. After the transfer, you will have standard follow-ups, including pregnancy tests and ultrasounds, to track your progress. Please note that those with certain medical conditions, such as repeated pregnancy loss or specific uterine problems, will not be able to participate. The trial is not yet recruiting participants, but it aims to provide valuable insights into improving outcomes for women trying to achieve pregnancy through IVF.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Plan to undergo single embryo transfer (SET) during the FET cycle.
• • Age between 18 and 45 years.
• • Patients with at least one high-quality blastocyst available for transfer.
• • Patients who have provided informed consent to participate in the study.
• Exclusion Criteria:
• • Patients with repeated implantation failure (RIF) or recurrent miscarriage (RM).
• • Patients with known uterine anomalies or significant uterine pathology (e.g., fibroids, polyps).
• • Patients who are unwilling or unable to provide informed consent.